Teucrium Soybean Fund Financials

SOYB

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Teucrium Soybean Fund (SOYB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SOYB FY2025 2026-04-22

Cash-rich but shrinking, the business has been absorbing multi-year losses mainly through equity erosion instead of heavy borrowing so far.

Losses and cash use are easing together: from FY2023 to FY2024, net loss improved by about $25.6M and operating cash outflow improved by about $16.2M. Because those two measures moved in the same direction, the recent improvement looks more like reduced cash drain than an accounting-only swing, even with FY2025 still showing a -$26.5M loss.

Liquidity remains the defining balance-sheet feature: FY2024 cash of $210.9M was close to the entire asset base of $241.7M. That means this is less a story of heavy reinvestment and more a story of how long a cash pool can absorb losses. FY2025 cash of $205.3M shows that cushion is still large, but no longer rebuilding.

Creditors are not carrying the strain: FY2024 liabilities were only $17.0M, far below cash and equity. That makes the main pressure point book value shrinkage; weak results reduce owners' capital directly instead of being masked by rising leverage.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Teucrium Soybean Fund's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$26.5M

YoY+44.6%

Teucrium Soybean Fund reported -$26.5M in net income in fiscal year 2025. This represents an increase of 44.6% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$205.3M

YoY-2.7%

5Y CAGR-7.9%

Teucrium Soybean Fund held $205.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

SOYB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	$88.6M+43.6%	$61.7M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$327K+16.0%	$281K-13.0%	$323K+7.3%	$302K+1.3%	$298K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$13.0M-26.8%	$17.7M+66.3%	$10.7M+1867.8%	$542K-59.9%	$1.4M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$26.5M+44.6%	-$47.9M+34.9%	-$73.5M+6.0%	-$78.2M-194.9%	$82.4M+46.8%	$56.2M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Revenue	N/A	$2.0M	N/A	N/A	$11.1M	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$71K-9.2%	$78K+10.5%	$71K+28.0%	$55K+4.5%	$53K-57.3%	$124K+152.2%	$49K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$3.0M-13.6%	$3.5M-4.9%	$3.7M-19.0%	$4.6M-1.4%	$4.6M+10.5%	$4.2M-3.1%	$4.3M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$56K+99.5%	-$10.9M+53.5%	-$23.5M-366.1%	$8.8M+130.4%	-$29.0M-27.1%	-$22.8M+25.0%	-$30.5M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SOYB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$241.7M-25.9%	$326.0M-35.5%	$505.5M+89.9%	$266.3M	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$205.3M-2.7%	$210.9M-27.8%	$292.2M-32.7%	$434.1M+72.1%	$252.2M-18.5%	$309.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$17.0M+49.4%	$11.4M-71.6%	$40.1M+1925.1%	$2.0M	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	$224.6M-28.6%	$314.5M-32.4%	$465.4M+76.1%	$264.3M	N/A
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Total Assets	$241.7M-6.1%	$257.4M-4.0%	$268.0M-9.6%	$296.7M-9.0%	$326.0M-11.7%	$369.0M+1.2%	$364.7M-7.1%	$392.4M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$210.9M-9.6%	$233.3M+2.3%	$228.1M-10.1%	$253.7M-13.2%	$292.2M-9.4%	$322.5M+3.7%	$311.1M-5.8%	$330.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$17.0M+67.0%	$10.2M-62.2%	$27.0M+43.0%	$18.9M+65.3%	$11.4M-58.4%	$27.4M-39.7%	$45.4M+28.8%	$35.3M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$224.6M-9.1%	$247.2M+2.5%	$241.0M-13.2%	$277.8M-11.7%	$314.5M-7.9%	$341.6M+7.0%	$319.3M-10.6%	$357.2M
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SOYB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$39.4M+29.1%	-$55.6M+47.7%	-$106.3M-241.3%	$75.2M+41.5%	$53.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	-$41.8M+51.5%	-$86.2M-129.9%	$288.1M+317.7%	-$132.3M-246.8%	$90.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$125.9M-52.5%	$264.9M-71.7%	$935.2M+214.0%	$297.8M+38.4%	$215.2M

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Operating Cash Flow	N/A	-$1.6M-911.4%	$199K+100.8%	-$25.5M-555.4%	$5.6M+114.6%	-$38.3M-542.9%	-$6.0M+64.9%	-$17.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	$6.9M+126.6%	-$25.8M-97.5%	-$13.1M+63.6%	-$35.9M-172.1%	$49.8M+479.0%	-$13.1M+84.9%	-$87.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$25.3M-47.1%	$47.8M+77.9%	$26.9M-52.4%	$56.4M+46.9%	$38.4M-35.3%	$59.3M-46.5%	$110.9M

SOYB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	93.0%+2.0pp	91.0%
Return on Equity	N/A	-21.3%+2.1pp	-23.4%-6.6pp	-16.8%-48.0pp	31.2%	N/A
Return on Assets	N/A	-19.8%+2.7pp	-22.5%-7.1pp	-15.5%-46.4pp	30.9%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	N/A	0.08+0.0	0.04-0.0	0.09+0.1	0.01	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	-2.8%	N/A	N/A	79.3%	N/A	N/A	N/A
Return on Equity	N/A	-0.0%+4.5pp	-4.5%+3.9pp	-8.5%-11.3pp	2.8%+11.3pp	-8.5%-1.3pp	-7.1%+1.4pp	-8.5%
Return on Assets	N/A	-0.0%+4.1pp	-4.1%+3.8pp	-7.9%-10.6pp	2.7%+10.6pp	-7.9%-1.6pp	-6.3%+1.5pp	-7.8%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.08+0.0	0.04-0.1	0.11+0.0	0.07+0.0	0.04-0.0	0.08-0.1	0.14+0.0	0.10
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

Is Teucrium Soybean Fund profitable?

No, Teucrium Soybean Fund (SOYB) reported a net income of -$26.5M in fiscal year 2025.

How financially healthy is Teucrium Soybean Fund?

Teucrium Soybean Fund (SOYB) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.